Motivational Interviewing

Author(s):  
Nancy P. Kropf ◽  
Sherry M. Cummings

In Chapter 8, “Motivational Interviewing: Evidence-Based Practice,” the research on the efficacy of motivational interviewing (MI) for achieving behavioral change in older adults is summarized and evaluated. Only meta-analyses and randomized controlled trails (RCTs) were included in the review. Fifteen RCTs were found that investigated the use of MI for enhancing behavioral change in older adults related to substance abuse/misuse, exercise, diet, and smoking. Beginning research on the use of MI with older clients suggests its efficacy for promoting behavioral change in this population. Results of randomized control trials reveal that MI is as effective as, or more effective than, other psychosocial interventions in fostering healthier behavior and improved mood. The studies discussed in this review were conducted in differing formats—face-to-face, telephone, and a combination of the two. The success of the telephone-based format, as well as the face-to-face approach, reveals the utility of MI interventions with homebound elders.

2020 ◽  
Author(s):  
Kengo Yokomitsu ◽  
Keita Somatori ◽  
Tomonari Irie

Through a randomized control design, this study examines whether tobacco consumption contributes to mood change and social enhancement in dyadic conversation. In addition, we would like to focus on the difference between smoking device and cigarette use. Specifically, we compare the intrapersonal and interpersonal communication in dyadic conversation among the cigarette group, the smoking device cigarette group, the water group, and the nothing consumption group. In the present study, 80 participants engaged in a dyadic, face-to-face, unstructured conversation with a stranger of the same gender. Regarding intrapersonal communication, no significant differences were found between the groups’ POMS 2 subscale scores (anger-hostility, confusion-bewilderment, depression-dejection, tension-anxiety, fatigue-inertia, vigour-activity, and friendliness). The smoking device and cigarette groups had greater rapport than the water group. Moreover, the smoking device group were more satisfied with dyadic conversation than the water group. Finally, there were no significant differences in verbal communication among the groups.


2013 ◽  
Vol 41 (4) ◽  
pp. 383-397 ◽  
Author(s):  
Richard Stott ◽  
Jennifer Wild ◽  
Nick Grey ◽  
Sheena Liness ◽  
Emma Warnock-Parkes ◽  
...  

Background: Randomized controlled trials have established that individual cognitive therapy based on the Clark and Wells (1995) model is an effective treatment for social anxiety disorder that is superior to a range of alternative psychological and pharmacological interventions. Normally the treatment involves up to 14 weekly face-to-face therapy sessions. Aim: To develop an internet based version of the treatment that requires less therapist time. Method: An internet-delivered version of cognitive therapy (iCT) for social anxiety disorder is described. The internet-version implements all key features of the face-to-face treatment; including video feedback, attention training, behavioural experiments, and memory focused techniques. Therapist support is via a built-in secure messaging system and by brief telephone calls. A cohort of 11 patients meeting DSM-IV criteria for social anxiety disorder worked through the programme and were assessed at pretreatment and posttreatment. Results: No patients dropped out. Improvements in social anxiety and related process variables were within the range of those observed in randomized controlled trials of face-to-face CT. Nine patients (82%) were classified as treatment responders and seven (64%) achieved remission status. Therapist time per patient was only 20% of that in face-to-face CT. Conclusions: iCT shows promise as a way of reducing therapist time without compromising efficacy. Further evaluation of iCT is ongoing.


2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S225-S225
Author(s):  
Jacob Lindsey ◽  
Elena Goodrich ◽  
Khoa Nguyen ◽  
Cierra Leon Guerrero ◽  
Colton Scavone ◽  
...  

Abstract Many older adults express a lack of confidence in using technology and this can become a barrier to participating in technology heavy research. This presentation will introduce the face-to-face digital communication, electronic medication adherence tracking, and online recruitment technology used in the I-CONECT study (ClinicalTrials.gov: NCT02871921). In particular, we will demonstrate how the project has simplified enterprise video conferencing for in-home use, removed obstacles related to remote hardware troubleshooting, and further discuss how it has been received by older adults who have participated thus far. Finally we will cover particular hurdles related to I-CONECT (e.g., targeting social isolated older adults, aiming to recruit 50% of participants being African American older subjects living in the Detroit Metropolitan area). Our experience indicates that such high tech gerontological research is feasible given a creative and solution-focused research approaches and multi-disciplinary team.


2021 ◽  
Vol 8 ◽  
Author(s):  
Beatrice Bassetti ◽  
Erica Rurali ◽  
Elisa Gambini ◽  
Giulio Pompilio

In the last decades, various non-pharmacological solutions have been tested on top of medical therapy for the treatment of patients affected by refractory angina (RA). Among these therapeutics, neuromodulation, external counter-pulsation and coronary sinus constriction have been recently introduced in the guidelines for the management of RA in United States and Europe. Notably and paradoxically, although a consistent body of evidence has proposed cell-based therapies (CT) as safe and salutary for RA outcome, CT has not been conversely incorporated into current international guidelines yet. As a matter of fact, published randomized controlled trials (RCT) and meta-analyses (MTA) cumulatively indicated that CT can effectively increase perfusion, physical function and well-being, thus reducing angina symptoms and drug assumption in RA patients. In this review, we (i) provide an updated overview of novel non-pharmacological therapeutics included in current guidelines for the management of patients with RA, (ii) discuss the Level of Evidence stemmed from available clinical trials for each recommended treatment, and (iii) focus on evidence-based CT application for the management of RA.


Sign in / Sign up

Export Citation Format

Share Document